Skip to main content

Addressing Misinformation

(BPT) - Frequently asked questions about Ozempic (semaglutide)

Novo Nordisk is a healthcare company with a 100­-year history of driving change to improve the lives of people living with serious, chronic diseases. As broader conversations about diabetes medicines are ongoing in both mainstream and social media, we believe it is important to continue to raise awareness and to reinforce our commitment to responsible use of Novo Nordisk medicines. These efforts are intended to support the safety of all people for one of our medicines that is well known in the diabetes community, Ozempic®.

See Medication Guide: bit.ly/OzempicPI & Safety Info: bit.ly/OzempicISI for Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg.




Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.68
-3.28 (-1.59%)
AAPL  279.42
+5.74 (2.10%)
AMD  211.29
-2.28 (-1.07%)
BAC  54.21
-1.18 (-2.13%)
GOOG  311.62
-7.01 (-2.20%)
META  660.47
-10.25 (-1.53%)
MSFT  403.32
-9.95 (-2.41%)
NVDA  191.81
+3.27 (1.73%)
ORCL  156.14
-3.75 (-2.35%)
TSLA  423.72
-1.49 (-0.35%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.